Unimark Remedies Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TOPIRAMATE USP, with a corresponding US DMF Number 20932.
Remarkably, this DMF maintains an Active status since its submission on October 05, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 31, 2013, and payment made on July 18, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II